MENA Metabolic Conference
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
Clinical Laboratory int.
  • Allergies
  • Cardiac
  • Gastrointestinal
  • Hematology
  • Microbiology
  • Microscopy & Imaging
  • Molecular Diagnostics
  • Pathology & Histology
  • Protein Analysis
  • Rapid Tests
  • Therapeutic Drug Monitoring
  • Tumour Markers
  • Urine Analysis

Archive for category: Product News

Product News

C332 Stago crop

Improved PT reagent

, 26 August 2020/in Product News /by 3wmedia

The Prothrombin Time test is the cornerstone of the coagulation discipline, representing over 50% of tests performed worldwide. Using a LEAN-based approach to cost reduction and improved patient safety, STA-NeoPTimal is a high performing PT reagent which is adapted to all types of laboratory workflows. For an optimal management, the new reagent offers a flexible solution with a range of 3 packaging sizes (5, 10 and 20 mL). It is the only tissue-extract PT and precalibrated reagent with an ISI = 1, with instrument-specific ISI values assayed against international standards and optimal sensitivity to changes in factor concentrations. The ease-of-use STA-NeoPTimal reagent offers user confidence and safety thanks to a fully validated system: fully automated barcoded reagent management with QC ranges for all Stago analysers and validated for evaluation of exogenous factors (II, V, VII and X); automatic Mean Normal Prothrombin Time (MNPT) calculation with STA Coag Expert module and a unique Viscosity-based Detection System (VBDS) insensitive to analytical interferences, such as hemolysis, icterus and lipelmia (HIL samples).
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C332_Stago_crop.jpg 730 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:21:23Improved PT reagent
C298 Hologic

Assay for chlamydia and gonorrhea cleared for throat and rectal specimens

, 26 August 2020/in Product News /by 3wmedia

Hologic’s Aptima Combo 2 Assay for Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) has received new CE-marked claims in Europe. These additional claims allow for testing of both clinician- and patient-collected throat and rectal swabs. These new samples, which can now be collected by the patient or the clinician using the Aptima Multitest Swab Specimen Collection Kit, broaden the range of patient-collected samples available. The excellent performance of the assay across sample types is reflected in throat and rectal samples, where Aptima Combo 2 demonstrates up to 100% sensitivity and specificity in detecting chlamydia and gonorrhoea. The APTIMA Combo 2 Assay can be used to test endocervical, throat, rectal, and male urethral swab specimens; female and male urine specimens; and cervical samples collected in PreservCyt Solution from symptomatic and asymptomatic individuals. The Aptima Combo 2 assay provides an upfront biological advantage compared to assays that detect DNA – up to 1,000-fold more rRNA than DNA per cell. The assay can be run as a standalone test or run simultaneously with other assays, providing clinicians with more flexibility. Chlamydia and gonorrhea are the most common notifiable sexually transmitted infections, and most chlamydial infections in the throat and rectum are asymptomatic. The European Centre for Disease Prevention and Control (ECDC) reported that in 2013, 384,555 cases of chlamydia infection were reported in 26 EU/EEA Member States, translating into an overall rate of 182 notifications per 100 000 population. Two-thirds (67%) of all chlamydia infections were reported in young people between 15 and 24 years of age, with the highest rates reported among women aged 20 to 24 years (1,717 cases per 100,000 population). The study also stated that the true incidence of chlamydia is likely to be considerably higher than the reported rates due to the asymptomatic nature of the infection. The ECDC also stated that in 2013, 52,995 gonorrhea cases were reported in 28 countries of the EU/EEA, with three times more cases in men than in women. Nearly half of all gonorrhea cases in 2013 (43%) were reported in men who have sex with men. Incidences of gonorrhea have increased 79% since 2008, a trend seen in most EU/EEA Member States.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C298_Hologic.jpg 466 640 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:21:31Assay for chlamydia and gonorrhea cleared for throat and rectal specimens
C270 EKF 01

New connectivity for point-of-care HbA1c analysers

, 26 August 2020/in Product News /by 3wmedia

A new connectivity package for EKF’s Quo-Test and Quo-Lab HbA1c analysers enables secure bidirectional communication between these POC analysers and a multitude of central data management systems. Using the industry recognized POCT1-A2 communication protocol, EKF’s connectivity solution unlocks a host of new features aimed at improving security and quality control (QC) for diabetic HbA1c testing. The new connectivity package includes a proprietary connector interface box, cables and a software upgrade. This enables EKF’s HbA1c analysers to automatically transmit patient data to the majority of Lab Information Management Systems (LIMS) or Hospital Information Systems (HIS). Traceability and results recall speed are improved by use of patient ID and increased demographic data (such as family name and date of birth). These can now be recorded through either selecting from a pre-approved list or via the barcode scanner and keyboard. Also ensuring the integrity of results generated at the POC, security and QC are enhanced on Quo-Lab and Quo-Test through user ID and QC lockout functions which are included in the connectivity package. By restricting access to trained users only, the lockout functions minimize the chances of user error and adhere to security protocols in many institutions. Furthermore, unauthorized users will be prevented from accessing patient information. Multiple user-defined QC lockout options are also available to POCT coordinators in order to enforce regular testing of QC materials and ensure compliance. HbA1c, or glycated hemoglobin, is well recognized as a reliable measure for glycemic control and managing patients with diabetes. As HbA1c levels reflect average circulating glucose concentration over a two to three month period, this means that it can offer greater clinical information than a single glucose measurement. Quo-Lab and Quo-Test analysers deliver lab-quality results for HbA1c from 4μL of blood within 4 minutes, enabling the consulting clinician to give immediate feedback to a patient. In addition to ensuring the reliability of results, the new connectivity package also allows the clinician to add commentary to any test result, further enhancing the monitoring and management of diabetes in a point-of-care setting.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C270_EKF_01.jpg 533 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:27:13New connectivity for point-of-care HbA1c analysers
C322 Siemens

Atellica Solution, advanced diagnostic analysers now available for sale

, 26 August 2020/in Product News /by 3wmedia

Siemens Healthineers announced recently the CE Mark and global commercial availability of its Atellica Solution – flexible, scalable, automation-ready immunoassay and chemistry analysers. The solution is now available across the globe in Europe, the United States, South America and Asia. The Atellica Solution is comprised of sample management, as well as immunoassay and chemistry analysers, and is an excellent fit for mid-and high-volume labs. It delivers unprecedented flexibility to adapt to changing testing needs and space constraints. The solution can combine up to 10 components into more than 300 customizable configurations – including linear, L and U shapes. It can operate as a stand-alone system or connect to Aptio Automation to provide a comprehensive, multidisciplinary testing solution that could include clinical chemistry, immunoassay, hemostasis, hematology, and plasma protein analysers. Further, with an immunoassay analyser that runs up to 440 tests per hour, the Atellica Solution delivers industry-leading productivity per square meter.
One key feature is the Atellica Magline Transport, the patented bi-directional, magnetic transport technology that is 10 times faster than conventional sample conveyors, and provides innovative and unique sample management capabilities. The transport technology, together with a multi-camera vision system, intelligent sample routing, and automatic quality control (QC) and calibration, give laboratories independent control over every individual sample – from routine to STAT – to deliver rapid, high quality patient results to clinicians. The Atellica Solution simplifies laboratory operations through intelligent sample management. It can process more than 30 different sample container types, including pediatric and tube-top sample cups that can be aspirated from the primary tube. Further, by using the same reagents and consumables across different analyser configurations, laboratories can streamline inventory and deliver consistent patient results no matter where patients are tested. Powering the Atellica Solution is a comprehensive menu of 170 assays, including 10-minute turnaround times for key cardiac, reproductive and thyroid tests, with 50 more assays in the pipeline. The immunoassay analyser features a patent-pending dual incubation ring design, temperature and humidity controls of the reaction environment, powerful magnets for relevant particle separation and robust washing protocols – all of which enable delivery of rapid, high precision results.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C322_Siemens.jpg 518 690 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:21:26Atellica Solution, advanced diagnostic analysers now available for sale
HORIBA Solution HELO pic for top product 2

New high-range hematology system

, 26 August 2020/in Product News /by 3wmedia

In order to meet the needs of the mid-high size laboratories segment, HORIBA Medical has developed a new high range solution in hematology : the HELO Solution (HELO : HORIBA Evolutive Laboratory Organisation). Based on the combination of innovative and proven technologies, it is perfectly suited to laboratories whose throughput extends from 300 to 20,000 tubes per day. The analysers Yumizen H2500 / H1500 and SPS (slide stainer) are the new analytical cores of this system. The overall results (patients and quality controls) produced by the instruments are analyzed, checked and validated by the Yumizen P8000, a new generation of specialized hematology validation station (Middleware). This solution allows laboratories organized in multi-sites to centralize data management, optimize automatic validation of results (customizable rules engine), while controlling productivity, thanks to real-time performance indicators (status connection, maintenance, TAT, manual validation, etc.). The management of reagents and waste has been optimized and is an integral part of the HELO Solution. In addition, the company’s system of connected analytical devices and high throughput tube conveyer, the Yumizen T6000 connection automation system, allows the link of all the analysers. Based on several patents, the Yumizen T6000 system optimizes the flow of tubes, in order to offer the best possible TAT. It offers 4 types of configuration: linear to replace identical configurations; angle to adapt the configuration of your laboratory; workcell to maximize personnel efficiency and island to minimize the floor area. Combined with the QAP programme (Quality Assurance Programme) the HELO Solution is in full compliance with ISO 15189.

Come and see us at EuroMedLab 2017
Booth #14 (Skalkotas Hall – Level -1)
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/HORIBA_Solution_HELO_pic_for_top_product_2.jpg 454 806 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:27:06New high-range hematology system
C257 Buhlmann 01

Immuno-turbidimetric fecal Calprotectin Assay

, 26 August 2020/in Product News /by 3wmedia

Fecal calprotectin (fCAL) is the most important marker for in vitro diagnostic detection of gut inflammation. Immunological quantitation is well established and is used in the diagnostic work-up of inflammatory bowel diseases (IBD) and in the lifelong monitoring of these chronic conditions.
fCAL testing today requires a raised level of lab resources including stool sample handling, extraction and the use of traditional immunological testing methods, i.e. ELISA.
The BÜHLMANN fCAL turbo assay is a big step towards full automation. It reduces the time to result to 10 minutes and the total hands-on time significantly. It offers the possibility of random access on your existing clinical chemistry platform. Validated applications are available for many analysers.
The combination with the proprietary extraction device CALEX Cap for pre-analytical sample preparation simplifies and accelerates stool diagnostics significantly. The BÜHLMANN fCAL turbo utilizes the well-established standardization of the BÜHLMANN fCAL ELISA to provide reliability, comparability and continuity of measurements.

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C257_Buhlmann_01.jpg 600 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:27:16Immuno-turbidimetric fecal Calprotectin Assay
C314 Beckman image2

Flow cytometry platform offers ultraviolet and infrared lasers

, 26 August 2020/in Product News /by 3wmedia

Beckman Coulter Life Sciences has opened up the possibilities for cancer researchers with the launch of the first flow cytometer to offer excitation sources across the visible spectrum in a standard configuration. The CytoFLEX LX Blue-Red-Violet-Yellow Green-Ultraviolet-Infrared series incorporates excitation sources from ultraviolet 355 nm to infrared 808 nm alongside the existing Avalanche photodiode detectors (APD).  For the first time, this allows researchers to utilize the periphery of the visible spectrum. The CytoFLEX provides powerful analytical performance in a compact, benchtop instrument.  It leverages the effective use of Avalanche photodiode detectors to deliver the instrument’s advanced sensitivity. They work in conjunction with the different lasers, detecting the light emitted from the cells after excitation.  The addition of the new ultraviolet laser further expands the applications available to the researcher. While flow cytometry is recognized as a powerful technique for single cell analysis, traditionally it has focused on the centre of the visible light spectrum. The availability of the UV excitation source opens up research into cell-cell interactions under both normal and abnormal conditions.  For example, this will enable investigators to obtain separation of non-stained auto-fluorescing populations from positively stained populations. At the other end of the spectrum lie the infrared wavelengths, 808 nm. This is a field where more and more detectors are packed into an already crowded space.  The opening up of the infrared end of the spectrum sees an exciting expansion of the capabilities of flow cytometry.  Biologists will have space in the spectrum to simplify complex experiments, helping them tease apart subtle, but potentially meaningful, variations in their cellular analyses. The decision to incorporate Avalanche photodiode detectors, not available in other flow cytometers, in the design of the original CytoFLEX makes this expansion possible.  With their high and stable quantum efficiency from 400 to 1100 nm, they can enhance performance when using the new infrared laser.  In addition, the CytoFLEX includes an extensive set of repositionable band pass filters, the flexibility to upgrade by adding additional parameters and intuitive software to facilitate multicolour analysis.  

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C314_Beckman_image2.jpg 542 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:21:29Flow cytometry platform offers ultraviolet and infrared lasers
C277 Fujirebio

Fully automated assay aiding in the early diagnosis of neurodegeneration

, 26 August 2020/in Product News /by 3wmedia
Fujirebio Europe recently launched the Lumipulse G ß-Amyloid 1-42 assay for its fully automated LUMIPULSE immunoassay systems. This CE-marked CLEIA (chemiluminescent enzyme immunoassay) kit allows the quantitative measurement of ß-amyloid in human cerebrospinal fluid within just 30 minutes. The Lumipulse G ß-Amyloid 1-42 assay is based upon Fujirebio’s well established, pioneering ELISA-based INNOTEST assay (the first neurodegeneration testing kit launched in 1995) and the know-how of Fujirebio in robust and automated CLEIA testing since the first LUMIPULSE instrument was released in 1992. The Lumipulse G ß-Amyloid 1-42 assay is the first fully automated testing solution for early detection of Alzheimer’s disease. It gives clinical laboratories access to more precise and reliable neurodegeneration testing and, of course, significantly faster results. Alzheimer’s disease starts silently, and develops several years before clinical symptoms appear. Until recently, it has been difficult for physicians to predict which individuals with memory problems will eventually develop AD, and which ones will not. New diagnostic tools to help detect AD as early as possible, and make early diagnosis with the highest level of certainty are of fundamental importance for both physicians and the patients and families involved. This is because memory complaints can result from several causes and may be reversible. Another reason that early detection tools are urgently needed is because it is believed that the treatment of diseases such as AD ideally should begin as soon as possible. Pharmaceutical companies trying to develop new AD treatments need reliable tests to establish clear-cut treatment groups, and means of monitoring the effectiveness of candidate treatments. 

Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C277_Fujirebio.jpg 434 651 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:27:11Fully automated assay aiding in the early diagnosis of neurodegeneration
C246 DiaSys crop 01

Automated POCT analyser

, 26 August 2020/in Product News /by 3wmedia

InnovaStar is an automatic compact POCT analyser for the daily practice that delivers result quality comparable to laboratory analysers for HbA1c, CRP, glucose and hemoglobin directly from a single 10 μl whole blood sample. The complete measurement procedure, including a sample individual hematocrit correction, is performed automatically thus reducing any handling errors. The newly integrated 2.8” colour touch-screen further improves the ease of use of the instrument, enabling the operator to enter any information such as patient data, user identification etc. The new graphical user interface allows a more efficient access to all soft ware functions and displays on-screen instructions where required. The up-to-date soft ware uses self-explanatory icons for a nearly languageindependent operation of the instrument.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C246_DiaSys_crop_01.jpg 800 696 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:27:18Automated POCT analyser
C336 Olympus

Microscope camera

, 26 August 2020/in Product News /by 3wmedia

Optimized for sharing, documenting and publishing, the fast 18-megapixel SC180 camera uses the full optical resolution of the microscope and produces clear, crisp images at all magnifications. The 4K UHD live image helps to engage audiences in large-screen presentations and to increase throughput in tissue documentation and creating detailed images for publication. The SC180 camera provides the benefits of 4K microscopy which enables users to get the same level of detail on the screen as through the oculars and shows true-to-life structures and colours for enhanced sample observation. To guarantee the highest quality of images, the SC180 camera offers fully automated, real-time image processing features. Olympus Smart Image Averaging (OSIA) reduces noise for crisp, clean images; real-time colour profiling with automated white point calibration ensures natural-looking colours for reliable images. Speeding up routine imaging, the SC180 also has Focus Peaking technology as well as a Fast Live function to improve throughput and productivity. Focus Peaking enables users to see which areas of a specimen are exactly in focus and get the desired image with the first click. Fast Live maintains a high frame rate when the specimen is being moved to ensure comfortable, fluid navigation regardless of the illumination conditions.
Read more

https://clinlabint.com/wp-content/uploads/sites/2/2020/08/C336_Olympus.jpg 800 800 3wmedia https://clinlabint.com/wp-content/uploads/sites/2/2020/06/clinlab-logo.png 3wmedia2020-08-26 09:17:532021-01-08 11:21:23Microscope camera
Page 128 of 152«‹126127128129130›»
Bio-Rad - Preparing for a Stress-free QC Audit

Latest issue of Clinical laboratory

March 2026

CLi Cover MRCH 2026
11 March 2026

Isomorphic Labs unveils IsoDDE, a unified AI drug design engine surpassing AlphaFold 3 in biomolecular prediction

11 March 2026

Androgen testing for PCOS diagnosis

9 March 2026

DiaSys Diagnostic Systems | ACE FS

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The leading international magazine for Clinical laboratory Equipment for everyone in the Vitro diagnostics

Sign up today
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Free subscriptions
    • Media kit
    • Submit Press Release
clinlab logo blackbg 1

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com

PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Subscribe now!

Become a reader.

Free subscription